Publication | Open Access

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial

Additional AnalysesUrologyOncologyCancer ManagementClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseaseMedicine